KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Kazia presents PK data for paxalisib at AACR meeting, page-4

  1. 3,137 Posts.
    lightbulb Created with Sketch. 383
    Very exciting times...

    He added, “a lot of our efforts at present are focused on assembling the complex package of scientific information that is required to secure FDA approval for any new drug. Today’s data provides one more piece in that jigsaw."
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.